News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Simpirica Spine, Inc. Receives Approval to Begin U.S. IDE Pivotal Study of Its LimiFlex™ Spinal Stabilization System


3/15/2012 7:03:13 AM

SAN CARLOS, Calif.--(BUSINESS WIRE)--Simpirica Spine Inc. developer of minimally invasive, flexion-restricting stabilization devices for the spine, has announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal clinical study of its LimiFlex Spinal Stabilization System. The LimiFlex is a novel dynamic stabilization system designed to address flexion (forward bending) pain and instability without the need for spinal fusion.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES